The anesthetic of choice is Isoflurane (also known as Forane). This anesthetic is effective through inhalation. The 30% v/v isoflurane in propylene glycol (1,2-Propanediol USP grade Sigma Cat no. P4347) can be administered through a nose cone system and can anesthetize the rats for a minimum of 8 minutes. The dosage of the anesthetic which is under consideration is 4% to anesthetize the rats, followed by 2% to retain the effect of the anesthetic. Multiple sources claim that administering Isoflurane requires a precision vaporizer, while others claim that a nose cone can be used for administering the anesthetic. Just to be completely sure, I’m delving deeper into both options. I will also try and ask a professional veterinarian about this for another opinion. ( a new post to come certainly)
The proper dosage of the crociodolite can only be determined from previous experimentation that involved the same carcinogen. This article states that 25 mg of crociodolite induced tumors in the rats within 6-24 months. Other doses included 50 mg, 2 mg, 50 µg and 100 µg (please refer to the graphs on page 5 for 50 µg and 100 µg)…the spectrum is clearly rather broad. However, the article above that has been included for reference was written to describe an experiment considerably similar to this one– but differs by its rather more emphasis on the toxicology and pathology analysis if the carcinomas/ carcinogen asbestos in the peritoneum– states that the rats contracted tumors in between 6-24 months with corresponding dosages of particular asbestos, and because this experiment will not last 6-24 months, it seems the dosage we will be using is at least 50 mg.
One possibility to induce the carcinogen in a more controlled fashion (in the sense administration of asbestos can be ualted or continued with he previous dosage) is to administer the carcinogen gradually over a period of time. For example, 1 mg may be administered the first week, and then 2 mg the next week, and then 4 mg the week after, etc. until signs of cancerous growth are imminent. The opposite is also possible: we could begin with 50 mg and then gradually lower how much crociodolite is administered week by week (45 mg the next week, 40 mg the week after, 35 mg after that, etc.). Either method (I personally find the latter to be more effective because it is evident that a relatively greater amount of the carcinogen will need to be administered for quicker effect) will help to determine when a proper amount of the carcinogen has finally been administered to the rats to prevent an overdose of, or too little, crociodolite. However, these methods do introduce another manipulated variable, if we have 2 variable groups hence the difference between the variable groups is a manipulated variable and the increasing or decreasing dosage gradients is another manipulated variable. It could raise an argument to the fact that since we are solely centering the project as an analytical model around irregular tissue growth in one specific organ, we only need visually apparent tumors in the CT to verify our method. We are not studying the effects of different dosages just using rats with mesothelioma to conjure a model that simulates living tissue with cancer. Mesothelioma induced with asbestos just ended up to be the best candidate.
The intraperitoneal injection is still what will likely be used to administer the crociodolite to the rats. 50 mg of crociodolite, for example, could be suspended in 2 mL of NaCl. 2 mg of crociodolite would be suspended in 2 mL of 0.9% NaCl. Saline, as mentioned in the “Thoughts For Experimentation” post on the “Biological Aspect” page, will most likely serve as the type of solution to be mixed with the crociodolite for an effective injection.
